Not currently recruiting at UCSF
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Mitsubishi Tanabe Pharma America Inc.
- ID
- NCT04683848
- Phase
- Phase 2 Spinal Cord Injury Research Study
- Study Type
- Interventional
- Participants
- Expecting 72 study participants
- Last Updated